Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: intranasal delivery

October 2, 2024 Drug delivery / Pharma applications

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting

The surge in neurological disorders necessitates innovative strategies for delivering active pharmaceutical ingredients to the brain. The non-invasive intranasal route

Continue reading

April 18, 2022 Drug delivery / Pharma applications

Strategies to Improve Drug Strength in Nasal Preparations for Brain Delivery of Low Aqueous Solubility Drugs

Intranasal administration is a promising route for brain drug delivery. However, it can be difficult to formulate drugs that have

Continue reading

October 12, 2021 CD as API / Drug delivery / Pharma applications

Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as

Continue reading

November 18, 2020 CD as API / CD derivatives / Pharma applications

Oxidized CD bisulfite against influenza A virus

Previous reports have demonstrated that compounds based on sulfo derivatives of oligo- and polysaccharides possess high antiviral activity. In this

Continue reading

Recent Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Exploring Cyclodextrin-Based MOFs for Drug Delivery: Synthesis, Applications, and Future Perspectives
  • Sugammadex analog water soluble BCD polymer for peptide complexes
  • 2 nd International Conference on Biomedical Science and Engineering

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (26)
  • Analysis (64)
  • CD as API (343)
  • CD derivatives (404)
  • Cosmetics and toilettry (49)
  • Diagnosis (12)
  • Drug delivery (786)
  • E-ducation (63)
  • Environmental (133)
  • Events (233)
  • Food (221)
  • Gene delivery (20)
  • Household products (4)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (42)
  • Non-pharma applications (396)
  • Other industrial use (104)
  • Pharma applications (1,173)
  • Supramolecular systems (40)
  • Uncategorized (144)

Top Posts

  • Cyclodextrin Produced In situ: Rethinking Oat Milk Design for Better Performance
  • Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications
  • Cyclodextrin-based formulations for pediatric patients: pharmaceutical prospectives and toxicological evaluation
  • Lanosterol eye drops for cataract treatment
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • Antiepileptic drug with betadex sulfobutyl ether sodium, Fycompa® injection approved in Japan
  • "Advances in Functional Materials" International Conference, 2021
  • Alterations in Proteostasis Mechanisms in Niemann–Pick Type C Disease
  • Aequus and reVision to Collaborate on Stargardt Disease Program using SBECD as active

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 3,791 other subscribers

Loading Comments...